Relapsed Synovial Sarcoma: Treatment Options.
Mia C WeissBrian A Van TinePublished in: Current treatment options in oncology (2023)
Synovial sarcoma (SS) is a fusion-driven subtype of sarcoma that is a more chemo-sensitive subtype of soft tissue sarcoma. While chemotherapy options are currently standard of care, our fundamental understanding of the biology of SS is driving new therapies. We will review the current standard of care, as well as the current therapies showing promise in a clinical trial. It is our hope that by encouraging participation in clinical trials, the fundamental therapies available for SS will change the current treatment paradigm.
Keyphrases
- clinical trial
- healthcare
- palliative care
- quality improvement
- locally advanced
- acute lymphoblastic leukemia
- phase ii
- acute myeloid leukemia
- physical activity
- randomized controlled trial
- pain management
- open label
- diffuse large b cell lymphoma
- affordable care act
- photodynamic therapy
- hodgkin lymphoma
- cancer therapy
- machine learning
- combination therapy
- double blind
- big data
- drug delivery
- replacement therapy
- rectal cancer